🇺🇸 FDA
Patent

US 9084782

Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis

granted A61KA61K31/18A61K31/435

Quick answer

US patent 9084782 (Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis) held by The Regents of the University of California expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/18, A61K31/435, A61K31/4418, A61K31/4436